Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.00
-0.30 (-4.11%)
Aug 20, 2025, 4:00 PM - Market closed

Kazia Therapeutics Revenue

Kazia Therapeutics had revenue of 22.29K AUD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 2.50M, up 248,983.08% year-over-year. In the fiscal year ending June 30, 2024, Kazia Therapeutics had annual revenue of 2.48M with 248,000.00% growth.

Revenue (ttm)
2.50M AUD
Revenue Growth
+248,983.08%
P/S Ratio
3.22
Revenue / Employee
278,143 AUD
Employees
9
Market Cap
7.83M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20242.48M2.48M248,000.00%
Jun 30, 20231,000.00-9.00K-90.00%
Jun 30, 202210.00K-15.17M-99.93%
Jun 30, 202115.18M14.19M1,436.54%
Jun 30, 2020988.11K-451.89K-31.38%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings